Label: EXOSCRT DERMA SIGNAL SRLV VIAL 1. LYOPHILIZED- leucine, isoleucine powder

  • NDC Code(s): 72951-140-01, 72951-140-02
  • Packager: Exocobio Inc.
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated January 17, 2023

If you are a consumer or patient please visit this version.

View All Sections
  • ACTIVE INGREDIENT

    Leucine 0.05%
    Isoleucine 0.05%

  • INACTIVE INGREDIENTS

    Rosa Damascena Callus Extracellular Vesicles, Methionine, Trehalose, Mannitol, Glutamine, Potassium Chloride, Ascorbic Acid, Retinol, Magnesium Sulfate, Glutathione, Nicotinamide Adenine Dinucleotide, Disodium Flavine, Adenine Dinucleotide, Thiamine Diphosphate, Coenzyme A, sh-Oligopeptide-2, Acetyl Hexapeptide-8, Nonapeptide-1, Palmitoyl Tetrapeptide-7, Palmitoyl Tripeptide-1, sh-Oligopeptide-1, sh-Polypeptide-1, sh-Polypeptide-3, sh-Polypeptide-76, Copper Tripeptide-1, Palmitoyl Pentapeptide-4, Alanine, Arginine, Aspartic Acid, Glutamic Acid, Glycine, Histidine, Lysine HCL, Ornithine HCL, Phenylalanine, Proline, Serine, Threonine, Tryptophan, Tyrosine, Valine

  • PURPOSE

    Anti wrinkle

  • WARNINGS

    For external use only, not to be swallowed.
    In case of accidental ingestion, seek professional assistance.
    Avoid contact with eyes.
    If contact occurs, rinse eyes thoroughly with water.
    Stop using and consult a doctor if rash or irritation develops and lasts. Keep out of reach of children. Take proper precautions when opening.

  • KEEP OUT OF REACH OF CHILDREN

    KEEP OUT OF REACH OF CHILDREN

  • Uses

    ■ Helps improve wrinkle care, skin rejuvenation.

  • Directions

    ■ Mix Vial 1(Lyophilized Powder) and Vial 2(Diluent) thoroughly.
    Apply a proper amount of mixture around the facial area.
    * One time use ONLY.

  • Other Information

    Store at 2℃~8℃

  • Questions

    www.exocobio.com / sales@exocobio.com

  • PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

    Image of carton

  • INGREDIENTS AND APPEARANCE
    EXOSCRT DERMA SIGNAL SRLV VIAL 1. LYOPHILIZED 
    leucine, isoleucine powder
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:72951-140
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    Leucine (UNII: GMW67QNF9C) (LEUCINE - UNII:GMW67QNF9C) Leucine0.01 mg  in 20 mg
    Isoleucine (UNII: 04Y7590D77) (ISOLEUCINE - UNII:04Y7590D77) Isoleucine0.01 mg  in 20 mg
    Inactive Ingredients
    Ingredient NameStrength
    Methionine (UNII: AE28F7PNPL)  
    Trehalose (UNII: B8WCK70T7I)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:72951-140-025 in 1 CARTON10/01/2021
    1NDC:72951-140-0120 mg in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other10/01/2021
    Labeler - Exocobio Inc. (694828578)
    Registrant - Exocobio Inc. (694828578)
    Establishment
    NameAddressID/FEIBusiness Operations
    Exocobio Inc.694828578manufacture(72951-140)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!